EP1654002B1 — Compositions for delivery of therapeutics into the eyes and methods for making and using the same
Assigned to Allergan Inc · Expires 2009-10-07 · 17y expired
What this patent protects
The present invention provides for compositions for administering a therapeutically effective amount of a therapeutic component. The composition may include an ophthalmically acceptable carrier component; a therapeutically effective amount of a therapeutic component; and a retent…
USPTO Abstract
The present invention provides for compositions for administering a therapeutically effective amount of a therapeutic component. The composition may include an ophthalmically acceptable carrier component; a therapeutically effective amount of a therapeutic component; and a retention component which may be effective to reduce wettability, induce viscosity, increase muco-adhesion, increase meniscus height on a cornea of an eye and/or increase physical apposition to a cornea of an eye of a composition.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.